Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023382
Filing Date
2017-11-13
Accepted
2017-11-09 19:49:21
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20170930.htm 10-Q 2080634
2 EX-2.1 apvo-ex21_142.htm EX-2.1 372569
3 EX-10.2 apvo-ex102_143.htm EX-10.2 618787
4 EX-31.1 apvo-ex311_103.htm EX-31.1 18012
5 EX-31.2 apvo-ex312_102.htm EX-31.2 18187
6 EX-32.1 apvo-ex321_101.htm EX-32.1 9343
7 EX-32.2 apvo-ex322_100.htm EX-32.2 9204
8 GRAPHIC g201711100017079244074.jpg GRAPHIC 4583
9 GRAPHIC g201711100017079264075.jpg GRAPHIC 2538
  Complete submission text file 0001564590-17-023382.txt   8686169

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT apvo-20170930.xml EX-101.INS 1756099
11 XBRL TAXONOMY EXTENSION SCHEMA apvo-20170930.xsd EX-101.SCH 52891
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20170930_cal.xml EX-101.CAL 59902
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20170930_def.xml EX-101.DEF 186523
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20170930_lab.xml EX-101.LAB 387239
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20170930_pre.xml EX-101.PRE 321672
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 171192467
SIC: 2834 Pharmaceutical Preparations